Article Text

Download PDFPDF
Timing of onset of symptoms in people with idiopathic pulmonary fibrosis
  1. Thomas Hewson,
  2. Tricia M McKeever,
  3. Jack E Gibson,
  4. Vidya Navaratnam,
  5. Richard B Hubbard,
  6. John P Hutchinson
  1. Division of Epidemiology and Public Health, School of Medicine, University of Nottingham, Nottingham, UK
  1. Correspondence to Dr John P Hutchinson, C100 Clinical Sciences Building, City Hospital, Nottingham NG5 1PB, UK; johnhutch{at}doctors.org.uk

Footnotes

  • Competing interests RBH and TMM have received grants from GSK for the PROFILE study, which aims to examine longitudinal disease behaviour and potential biomarkers in IPF. JPH has received funding from GSK for delivering a teaching session on asthma, and from Actelion to attend a two-day preceptorship on pulmonary hypertension. TH, JEG and VN have no competing interests.

  • Ethics approval THIN Scientific Review Committee (SRC 14–047).

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Competing interests RBH and TMM have received grants from GSK for the PROFILE study, which aims to examine longitudinal disease behaviour and potential biomarkers in IPF. JPH has received funding from GSK for delivering a teaching session on asthma, and from Actelion to attend a two-day preceptorship on pulmonary hypertension. TH, JEG and VN have no competing interests.

  • Ethics approval THIN Scientific Review Committee (SRC 14–047).

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.